[U.S. pharmaceutical stocks continue to - Telegraph

B · Normal

[U.S. pharmaceutical stocks continue to rise after AstraZeneca's results, up more than 6%] On October 30, U.S. pharmaceutical stocks continued to rise, with AstraZeneca rising more than 6% after its results, and Q3 profits exceeding expectations; Eli Lilly and Gilead Sciences rose more than 4%, Amgen rose nearly 3%, and Johnson & Johnson rose nearly 2%. The intraday stock prices all hit record highs.

U.S. stock trends 🕐 2026-10-30 21:44

#Johnson & Johnson #U.S. stock trends #Global market intelligence

← Back to Telegraph

Related telegraphs

10月30日电，土耳其基准股指BIST100指数跌3%，土耳其主要银行指数跌2%。 10-30 22:38 On October 30, U.S. stocks continued to fall, with the Nasdaq 100 Index's declin 10-30 22:23 On October 30, Intel's five-year credit default swap expanded to a record high o 10-30 22:20 [The Security Council passed a resolution to extend the authorization of the Uni 10-30 22:19 On October 30, Starbucks plans to double the number of international stores to 4 10-30 21:47 [Higher international oil prices drive collective gains in energy stocks Exxon M 10-30 21:46

Comments

No comments yet